Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06744140

Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.

Detailed description

Improved detection rates of DCIS in high-risk patients. Enhanced diagnostic accuracy, reducing false positives and negatives. Ductal Carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts. The Breast Imaging Reporting and Data System (BI-RADS) is a standardized scoring system used to classify breast imaging findings. Scores range from 0 (incomplete) to 6 (known biopsy-proven malignancy)."

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic Resonance Imaging (MRI)To Evaluate the breast Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma In Situ (DCIS) lesions among high-risk breast cancer patients while keeping the histopathology as a GOLD standard

Timeline

Start date
2024-02-15
Primary completion
2024-07-01
Completion
2025-03-21
First posted
2024-12-20
Last updated
2024-12-20

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06744140. Inclusion in this directory is not an endorsement.